Headlines

Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis

Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis

The Decipher genomic classifier obtained from biopsy samples was prognostic for distant metastases and prostate cancer-specific mortality.

GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible

GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible

A phase 3 study presented at the 2017 Genitourinary Cancers Symposium demonstrated the feasibility of conducting adjuvant trials.

Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods

Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods

Annual lung cancer screening of only high-risk smokers more cost-effective than current methods.

Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome

Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome

Blood test combined with medical status information predicts stem cell transplant success in patients with MDS.

Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment

Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment

The mechanism of metronomic chemotherapy: Improved tumor blood supply leads to better treatment .

Immunotherapy and the Future of Prostate Cancer Treatment

Immunotherapy and the Future of Prostate Cancer Treatment

Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer.

Targeting AR Mutations Promising in Metastatic Prostate Cancer

Targeting AR Mutations Promising in Metastatic Prostate Cancer

A higher overall number of genetic alterations in cell-free circulating tumor DNA (ctDNA) were associated with worse treatment outcomes.

GUCS 2017: Early Immunotherapy Discontinuation in mRCC

GUCS 2017: Early Immunotherapy Discontinuation in mRCC

Patients with advanced renal cell carcinoma (RCC) who discontinued anti-PD-1/PD-L1 immunotherapy early may still achieve durable responses.

Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer

Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer

Clinical trials show pembrolizumab active against mucosal melanoma, extends survival in bladder cancer.

Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality

Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality

Risk for all-cause mortality is lower among older women treated for DCIS.

Conference Coverage

GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible

A phase 3 study presented at the 2017 Genitourinary Cancers Symposium demonstrated the feasibility of conducting adjuvant trials.

Targeting AR Mutations Promising in Metastatic Prostate Cancer

A higher overall number of genetic alterations in cell-free circulating tumor DNA (ctDNA) were associated with worse treatment outcomes.

GUCS 2017: Early Immunotherapy Discontinuation in mRCC

Patients with advanced renal cell carcinoma (RCC) who discontinued anti-PD-1/PD-L1 immunotherapy early may still achieve durable responses.

Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer

Clinical trials show pembrolizumab active against mucosal melanoma, extends survival in bladder cancer.

Onset or Rapid Worsening of Diabetes May Indicate Pancreatic Cancer

An investigation into whether onset or worsening of diabetes causes pancreatic cancer or vice versa was presented at the 2017 European Cancer Congress.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs